Abstract:Alzheimer's disease (AD) is the most common form of dementia, and the molecular mechanisms that underlie AD pathophysiology remain unclear. AMP-activated protein kinase (AMPK) is a Ser/Thr kinase that functions as a central energy sensor to maintain cellular energy homeostasis. Furthermore, AMPK integrates several signaling pathways controlling de novo protein synthesis (mRNA translation) which is vital for long-term synaptic plasticity and memory formation. Dysregulation of energy homeostasis and de novo protein synthesis are both implicated in AD. AMPK is a heterotrimeric protein with a catalytic α subunit and regulatory β/γ subunit. The α subunit of AMPK exists in two isoforms: α1 and α2, and their roles in AD are unknown. Post Mortem brain tissue from human AD was examined by both western blot and immunohistochemistry for AMPKα1 and AMPKα2 levels. AMPKα1 protein levels were selectively reduced in late development in the forebrain of Tg19959 AD model mice to generate AMPKα1(+/-)/Tg19959 double mutant mice. These mice were cognitively assessed by Morris Water Maze (MWM) and Novel Object Recognition (NOR) tasks. Hippocampal long-term potentiation (LTP) was measured to assess synaptic plasticity, moreover dendritic spine morphology was examined by Golgi Stain. In human hippocampal tissue AMPKα1 levels were dramatically increased, while levels of AMPKα2 were decreased in comparison with age-matched controls. These changes were neuronally localized and AD hippocampi specific. AD associated impairments of cognition and synaptic plasticity were alleviated in AMPKα1(+/-)/Tg19959 double mutant mice. Analysis of dendritic spine morphology revealed the hippocampal abnormalities in theTg19959 model mice were restored with genetic reduction of AMPKα1. AMPKα1 is abnormally neuronally upregulated in AD. Our results demonstrate that restoration of AMPKα1 levels in an AD model mouse ameliorates the behavioral and synaptic plasticity impairments. Our findings indicate AMPKα1 dysregulation as a molecular mechanism underlying AD pathophysiology, and providing insights into a potential therapeutic strategy.

Effect of AMPKα2 Knockdown on Alzheimer's Pathogenesis and Cognitive Deficits in Young Tg19959 Mice.

P2‐157: BRAIN‐SPECIFIC REPRESSION OF AMPKα1 ALLEVIATES MEMORY DEFICITS AND SYNAPTIC FAILURE IN A MOUSE MODEL OF ALZHEIMER'S DISEASE

Brain-specific repression of AMPKα1 alleviates pathophysiology in Alzheimer's model mice.

Brain-specific repression of AMPK1 alleviates pathophysiology in Alzheimer's model mice

Inhibition of AMP-Activated Protein Kinase Signaling Alleviates Impairments in Hippocampal Synaptic Plasticity Induced by Amyloid Β

Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid β.

Brain-specific Suppression of AMPKα2 Isoform Impairs Cognition and Hippocampal LTP by PERK-mediated Eif2α Phosphorylation

Isoform-specific effects of neuronal repression of the AMPK catalytic subunit on cognitive function in aged mice

Suppression of neuronal AMPKβ2 isoform impairs recognition memory and synaptic plasticity

Protein Expression Alteration In Hippocampus Upon Genetic Repression Of Ampk Alpha Isoforms

The Effect of Chronic Cerebral Hypoperfusion on Amyloid-β Metabolism in a Transgenic Mouse Model of Alzheimer's Disease (PS1V97L).

AMPK Ameliorates Tau Acetylation and Memory Impairment Through Sirt1

Isoform-specific Effects of Neuronal Inhibition of AMPK Catalytic Subunit on LTD Impairments in a Mouse Model of Alzheimer’s Disease

Therapeutic Potential of AMP-Activated Protein Kinase in Alzheimer’s Disease

Isoform-specific effects of neuronal inhibition of AMPK catalytic subunit on LTD impairments in a mouse model of Alzheimer's disease

Antagonists Targeting Eef2 Kinase Rescue Multiple Aspects of Pathophysiology in Alzheimer's Disease Model Mice

Genetic Reduction of Eef2 Kinase Alleviates Pathophysiology in Alzheimer’s Disease Model Mice

Isoform-specific dysregulation of AMP-activated protein kinase signaling in a non-human primate model of Alzheimer's disease

Homozygous knockout of eEF2K alleviates cognitive deficits in APP/PS1 Alzheimer's disease model mice independent of brain amyloid β pathology

Genetic Ablation of Hematopoietic Cell Kinase Accelerates Alzheimer’s Disease–Like Neuropathology in Tg2576 Mice

Akt activation ameliorates deficits in hippocampal-dependent memory and activity-dependent synaptic protein synthesis in an Alzheimer’s disease mouse model